You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-114. Primary opioids distribution among all clients entering treatment by country and type of treatment centre (%), 2011
| Country | Outpatient | Inpatient | Low-threshold agencies | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium | 20.7 | 654 | 3160 | 48.5 | 649 | 1339 | 61.7 | 873 | 1415 | |
| Czech Republic | 30.6 | 618 | 2021 | 19.3 | 451 | 2334 | 14.8 | 722 | 4862 | |
| Germany | 43.7 | 19680 | 45020 | 37.1 | 2516 | 6781 | 82.4 | 1309 | 1588 | |
| Greece | 77.3 | 2999 | 3882 | 87.0 | 1367 | 1571 | 89.1 | 327 | 367 | |
| Hungary | 5.7 | 215 | 3740 | 14.0 | 42 | 299 | 4.7 | 27 | 577 | |
Notes:
Only countries supplying data for all 3 types of treatments centres are reported
Percentages are of clients entering treatment in a given type of treatment centre and whose primary drug is known.
‘General notes for interpreting data'’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012 TDI - Outpatient, Inpatient and Low-threshold Treatment Centres